ArticleAmerican journal of translational research2025
Goal-directed fluid therapy improves volume loading and stabilizes hemodynamics in patients undergoing coronary artery bypass grafting.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Hemodynamic monitoring strategies in cardiac surgery: an update systematic review.Journal of clinical monitoring and computing · 2026Pooled it
- Improved Cardiac Function and Glycemic Control in Elderly Diabetic Patients Through Structured Case Management After CABG.Medical science monitor : international medical journal of experimental and clinical research · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the effects of goal-directed fluid therapy (GDFT) on volume load and hemodynamics in patients undergoing coronary artery bypass grafting (CABG).
methodsThis retrospective study analyzed data from 131 patients with coronary heart disease who underwent CABG between April 2020 and April 2023. Seventy-five patients who received GDFT were categorized as the observation group, while 56 patients who received routine liquid therapy served as the control group. Fluid intake and outflow, volume load, regional cerebral oxygen saturation (rSO
resultsThere were no significant group differences in total fluid input, red blood cell infusion rate, autologous blood transfusion rate, and bleeding amount between the two groups (all
conclusionGDFT improves cardiac function and reduces cardiac volume load in patients undergoing CABG. It helps stabilize intraoperative hemodynamics, reduces blood lactate levels, enhances oxygen supply to brain tissue (as reflected by improved rSO
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.